Search research articles
Contact Us
Filters
Showing results (1-10 of 12) with videos related to
Page
of 2
Sort By:
Pulmonary Pharmacology & Therapeutics
|
June 27, 2018
Effect of pirfenidone on gastric emptying in a rat model
Lin Pan, Thomas Gelzleichter, Yuan Chen, et al.
Expert Opinion on Investigational Drugs
|
October 25, 2021
Latest generation estrogen receptor degraders for the treatment of hormone receptor-positive breast cancer
Ya-Chi Chen, Jiajie Yu, Ciara Metcalfe, et al.
Journal of Immunotoxicology
|
June 11, 2013
Immunomodulation and lymphoma in humans
Rafael A Ponce, Thomas Gelzleichter, Helen G Haggerty, et al.
British Journal of Pharmacology
|
July 19, 2006
Preclinical pharmacokinetics, pharmacodynamics, and activity of a humanized anti-CD40 antibody (SGN-40) in rodents and non-human primates
Sean K Kelley, Thomas Gelzleichter, Dong Xie, et al.
Reproductive Toxicology (Elmsford, N.Y.)
|
May 24, 2016
Assessment of placental transfer and the effect on embryo-fetal development of a humanized monoclonal antibody targeting lymphotoxin-alpha in non-human primates
Hong Wang, Chris Schuetz, Akihiro Arima, et al.
Journal of Pharmacological and Toxicological Methods
|
April 17, 2018
A pharmacology guided approach for setting limits on product-related impurities for bispecific antibody manufacturing
Sharmila Rajan, Junichiro Sonoda, Timothy Tully, et al.
Molecular Cancer Therapeutics
|
November 22, 2013
Nonclinical evaluation of the serum pharmacodynamic biomarkers HGF and shed MET following dosing with the anti-MET monovalent monoclonal antibody onartuzumab
Elaine Mai, Zhong Zheng, Youjun Chen, et al.
The American Journal of Cardiology
|
March 28, 2017
Effects of RG7652, a Monoclonal Antibody Against PCSK9, on LDL-C, LDL-C Subfractions, and Inflammatory Biomarkers in Patients at High Risk of or With Established Coronary Heart Disease (from the Phase 2 EQUATOR Study)
Amos Baruch, Sofia Mosesova, John D Davis, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
November 3, 2020
Antibody-mediated activation of the FGFR1/Klothoβ complex corrects metabolic dysfunction and alters food preference in obese humans
Amos Baruch, Chin Wong, Leslie W Chinn, et al.
Regulatory Toxicology and Pharmacology : RTP
|
April 7, 2009
Immunogenicity of biologically-derived therapeutics: assessment and interpretation of nonclinical safety studies
Rafael Ponce, Leslie Abad, Lakshmi Amaravadi, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 12) with videos related to
Sort By:
Page
of 2
Pulmonary Pharmacology & Therapeutics
|
June 27, 2018
Effect of pirfenidone on gastric emptying in a rat model
Lin Pan, Thomas Gelzleichter, Yuan Chen, et al.
Expert Opinion on Investigational Drugs
|
October 25, 2021
Latest generation estrogen receptor degraders for the treatment of hormone receptor-positive breast cancer
Ya-Chi Chen, Jiajie Yu, Ciara Metcalfe, et al.
Journal of Immunotoxicology
|
June 11, 2013
Immunomodulation and lymphoma in humans
Rafael A Ponce, Thomas Gelzleichter, Helen G Haggerty, et al.
British Journal of Pharmacology
|
July 19, 2006
Preclinical pharmacokinetics, pharmacodynamics, and activity of a humanized anti-CD40 antibody (SGN-40) in rodents and non-human primates
Sean K Kelley, Thomas Gelzleichter, Dong Xie, et al.
Reproductive Toxicology (Elmsford, N.Y.)
|
May 24, 2016
Assessment of placental transfer and the effect on embryo-fetal development of a humanized monoclonal antibody targeting lymphotoxin-alpha in non-human primates
Hong Wang, Chris Schuetz, Akihiro Arima, et al.
Journal of Pharmacological and Toxicological Methods
|
April 17, 2018
A pharmacology guided approach for setting limits on product-related impurities for bispecific antibody manufacturing
Sharmila Rajan, Junichiro Sonoda, Timothy Tully, et al.
Molecular Cancer Therapeutics
|
November 22, 2013
Nonclinical evaluation of the serum pharmacodynamic biomarkers HGF and shed MET following dosing with the anti-MET monovalent monoclonal antibody onartuzumab
Elaine Mai, Zhong Zheng, Youjun Chen, et al.
The American Journal of Cardiology
|
March 28, 2017
Effects of RG7652, a Monoclonal Antibody Against PCSK9, on LDL-C, LDL-C Subfractions, and Inflammatory Biomarkers in Patients at High Risk of or With Established Coronary Heart Disease (from the Phase 2 EQUATOR Study)
Amos Baruch, Sofia Mosesova, John D Davis, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
November 3, 2020
Antibody-mediated activation of the FGFR1/Klothoβ complex corrects metabolic dysfunction and alters food preference in obese humans
Amos Baruch, Chin Wong, Leslie W Chinn, et al.
Regulatory Toxicology and Pharmacology : RTP
|
April 7, 2009
Immunogenicity of biologically-derived therapeutics: assessment and interpretation of nonclinical safety studies
Rafael Ponce, Leslie Abad, Lakshmi Amaravadi, et al.
Page
of 2